Immediate Impact
61 standout
Citing Papers
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Works of Jenny Nobes being referenced
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jenny Nobes | 158 | 85 | 107 | 31 | 327 | |
| I. Brown | 83 | 70 | 79 | 21 | 308 | |
| Jinlan He | 88 | 92 | 152 | 24 | 299 | |
| Duc Le | 141 | 95 | 62 | 25 | 283 | |
| Ljiljana Mijatović-Teodorović | 86 | 107 | 67 | 21 | 336 | |
| Andrea Emanuele Guerini | 112 | 97 | 72 | 32 | 343 | |
| Vignesh Viswanathan | 93 | 49 | 156 | 32 | 323 | |
| Chatal Jf | 85 | 49 | 45 | 27 | 367 | |
| Camilla Delli Paoli | 134 | 109 | 47 | 22 | 277 | |
| Louise Flanagan | 107 | 56 | 162 | 31 | 290 | |
| Sotaro Otake | 103 | 137 | 59 | 17 | 343 |
All Works
Login with ORCID to disown or claim papers
Loading papers...